2025年12月21日 / ライフスタイル

The new target for rejuvenation research is "how transcription ends" — Elongin A applies a proliferation brake

The new target for rejuvenation research is "how transcription ends" — Elongin A applies a proliferation brake

Is Aging Determined More by "How Genes Are Read" Than by "Genes" Themselves?

When people hear the word "aging," they often think of accumulated damage such as DNA damage, telomere shortening, and reactive oxygen species. These are indeed important factors. However, a research team from Northwestern Medicine has posed a different angle: the question of whether the progression of aging is influenced by **how cells "read" the DNA blueprint**. News Center


The focus of the research is on "transcription," the process of copying DNA into RNA. Specifically, it highlights the role of **transcription elongation factors** that act as "traffic controllers" to facilitate, halt, or terminate the process where RNA polymerase II transcribes along the DNA (elongation). News Center


Three Key Points to Note

  1. Long-term reduction of elongation factors such as NELF and SPT6 leads cells to stop proliferating, activating a set of genes associated with aging (senescence). Furthermore, this cessation is suggested to be reversible. News Center

  2. Through genetic screening, **Elongin A (ELOA)** emerged as a key factor in this proliferation arrest. It is involved in the "termination" of transcription and RNA processing, influencing the formation of the aging program. PubMed

  3. ELOA is particularly associated with the control of short stress response genes, supporting the view of aging as "transcription quality control." News Center

Why Are "Aging Cells" Important?

Cellular senescence is a state where cells stop dividing but remain alive, sometimes continuing to secrete inflammatory substances. While it is associated with age-related decline in tissue function, it also acts as a tumor suppressor to prevent uncontrolled proliferation. This dual role means that discussions about "reversing" aging always come with both hope and concern. This study hits right at the heart of this issue. News Center


Tweaking NELF and SPT6 Stops Cells—But Can They "Return"?

The research team focused on transcription elongation factors NELF and SPT6. Long-term reduction of these factors has been shown to stop cell proliferation and prematurely activate aging-related genes. Examples include **CDKN1A (p21)**, a well-known marker of aging. PubMed


What is interesting here is that the proliferation arrest is not a "permanent freeze." Reports suggest that changing conditions may allow proliferation to resume, indicating the possibility of reversible proliferation arrest/reversible aging (at least in cultured cell systems). News Center


The question "Can aging be reversed?" has long been a contentious issue in aging research. Other studies have reported cases where cellular senescence under certain conditions can be reversed through signal regulation (e.g., systems involving ATM signaling), suggesting that the "irreversibility" of aging is not absolute. Phys.org


So, Who Creates the Exit?—ELOA Emerges

In genetic screening conducted by the research team, **Elongin A (ELOA)** emerged as a key factor. According to reports, ELOA is involved in the "termination" of transcription where RNA polymerase II finishes at the end of a gene, as well as in RNA maturation (RNA processing). News Center


Delving deeper, ELOA is suggested to be involved in the processing defects of RNA precursors (pre-mRNA) and the behavior of polymerase "overshooting" beyond transcription termination sites (TES) that occur with NELF reduction, with the possibility that loss of ELOA suppresses these issues. PubMed


A significant practical impact is that loss of ELOA provided a growth advantage in primary fibroblasts derived from aged human skin. In other words, ELOA might act as a "growth brake" on aging cells. PubMed


The Scenario of "Short Genes × Stress Response × ELOA"

The news release also touches on the possibility that ELOA is particularly involved in the transcriptional control of short stress response genes. Short genes can be transcribed quickly, providing an advantage for rapid response to environmental changes—if this hypothesis is correct, aging is intertwined not only with "gene damage" but also with the very mechanism of rapidly initiating stress responses. News Center


This perspective aligns well with the recent trend linking "transcription quality (speed and accuracy)" to aging and lifespan. For example, past studies have suggested the possibility that transcription speeds up with aging while errors increase, or that interventions can change lifespan indicators. Phys.org


Looking Further: Does the "Repetition" of ELOA3 Create Individual Differences?

In this topic, ELOA3, a primate-specific homolog of ELOA, is mentioned. ELOA3 contains repeat sequences, and the number of repeats varies within populations, leading to the hypothesis that "natural genetic diversity may influence susceptibility to age-related diseases" in the future. News Center


Of course, at this stage, it is a matter of "possibility," but if this is proven, aging research will expand not only in the direction of "intervention (drugs)" but also "individual differences (genomic diversity)."


The Greater the Expectation, the Greater the Caution

This study suggests an intriguing map where aging might be adjusted by "tweaking the transcription apparatus." News Center


However, there are clear points of caution.

  • The insights are primarily from cultured cells

    , and whether they work safely in organisms (animals, humans) is another matter.

  • Since senescence also acts as a tumor suppressor, indiscriminate reversal could be risky for tumorigenesis.

  • Since transcription elongation factors are involved in the expression of many genes, targeted intervention might be challenging.

Instead of "stopping aging," the design of "which tissue's, which type of senescent cells, and to what extent to tweak" becomes increasingly important.


SNS Reactions (Few Direct Mentions → Organized by "Discussion Points")

This news is dense with molecular mechanisms, and at present, it seems that the type of widespread excitement and division of opinion based solely on article titles is limited on public SNS (at least within the searchable range, there are not many mass posts for the general public). Nonetheless, when the content is shared, the reactions that are likely to occur can be summarized by discussion points as follows.


  • Explosive Expectations: "Have We Found the Aging Switch?"
    Reactions like "If aging cells can 'return,' then it's a straight path to rejuvenation?" In reality, it's a discussion of "there might be conditions under which cells can resume proliferation," which is quite distant from individual rejuvenation. News Center

  • Cautious Voices: "Is It Safe to Remove Tumor Suppression?"
    Since senescent cells help stop uncontrolled proliferation, there are concerns like "reversal = promoting cancer," leading to discussions about balance.

  • Specialist Surprise: "Does Touching the End Matter?"
    Researchers and those in scientific fields find it interesting that the focus is on "how transcription ends/RNA processing" rather than "transcription speed." PubMed

  • Implementation Perspective: "Where's the Window for Drug Development?"
    Questions like "Which of NELF/SPT6/ELOA can be targeted with drugs? What about side effects?" The news release also mentions "therapeutic windows," which will be a focus of future research. News Center

  • Individual Difference Topic: "Does ELOA3 Repetition = Differences in Aging Susceptibility?"
    The discussion easily shifts to genetic testing and personalized medicine. However, currently, it's at the "possible" hypothesis stage. News Center

  • Skeptical Voices: "Isn't This Just a Petri Dish Story?"
    Reactions pointing out that "in vitro reversibility" may not directly apply to the human body. This is an important critique.##